Patents by Inventor Marie-Claude Guillemin

Marie-Claude Guillemin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Treating Cancer Based on the Modulation of Calcineurin
    Publication number: 20080293759
    Abstract: The present invention relates to methods for treating a haematopoietic tumor by administering a drug inhibiting calcineurin and/or the calcineurin/NFAT pathway, alone or in combination with other cancer therapy, pharmaceutical compositions useful in such methods, and screening methods for identifying a compound useful for treating a haematopoietic tumor.
    Type: Application
    Filed: November 16, 2006
    Publication date: November 27, 2008
    Applicant: Centre National De La Recherche
    Inventors: Jacques Ghysdael, Hind Medyouf, Marie-Claude Guillemin
  • Antigens of Leishmania parasites
    Patent number: 4992273
    Abstract: The invention concerns hybridomes producing anti-Leishmania monoclonal antibodies which are characterized by their capacity to inhibit the infection of sarcomatous cells by the promastigote forms of one or more species of Leishmania, when the sarcomatous cells are placed in contact with the said promastigote forms pre-incubated with these monoclonal antibodies under conditions which, in the absence of the said monoclonal antibodies, would lead to an elevated parasitemia in the said cells.These monoclonal antibodies and the proteins of the parasites that they recognize may be used in the operations of leishmanioses detections.
    Type: Grant
    Filed: July 31, 1986
    Date of Patent: February 12, 1991
    Assignees: Institut Pasteur, Universite de Technologie de Compiegne, Universite Pierre Et Marie Curie
    Inventors: Louis Monjour, Alberto Roseto, Armand Berneman, Marie-Claude Guillemin-Debons, Martine Domurado, George Peries